all press releases

  • 01/30/20
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. will join supply chain professionals, pharmaceutical industry representatives and other thought leaders for the Healthcare Supply Chain Association National Pharmacy Forum 2020. The conference entitled, “A 2020 Perspective on Healthcare and Pharmacy Leadership,” will be held Feb. 3-5 in Scottsdale, Arizona. Vizient experts will share their knowledge in two sessions and moderate one on Feb. 4: 503B Compounding Update 11 a.m. to noon The 503Bmore...
  • 01/29/20
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. released its Winter 2020 Drug Price Forecast projecting that health systems, including inpatient and non-acute environments, can expect a 3.59% increase for pharmaceutical purchases made from July 1 to June 30, 2021. While the forecasted percentage is lower than previous projections, the influence of expensive biologic therapies, oncology and oncology-related drugs, disease-modifying antirheumatic drugs (DMARDs), and immunomodulators on overallmore...
  • 01/28/20
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. yesterday submitted comments to the Food and Drug Administration (FDA) in response to its draft guidance, “Clinical Immunogenicity Considerations for Biosimilar and Interchangeable Insulin Products.” We applaud the FDA’s draft guidance which clarifies that a comparative clinical immunogenicity study may not be necessary for approval of certain proposed biosimilar and interchangeable insulin products. Vizient believes FDA’s draft guidance willmore...
  • 01/27/20
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. has identified 200 essential medications whose absence may threaten hospitals’ ability to provide immediate and high quality patient care, including 77 acute and chronic life-saving drugs that have no alternatives in the event of a supply disruption. The medications designated as essential with no alternatives include vital chemotherapy drugs and life-saving reversal agents such as epinephrine (allergic reactions) and naloxone (opioid overdoses).more...
  • 12/20/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today praised the work of the House and Senate in approving year-end spending legislation that includes the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. This bipartisan legislation will encourage new generic drug competition and help lower prescription drug costs for hospitals and patients. The CREATES Act prevents brand name drug manufacturers from using tactics that slow the development and entry of new, lower costmore...
  • 12/10/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced new, renewed or expanded member agreements with 16 health care organizations in the third quarter of 2019, including academic medical centers, community hospitals, integrated health delivery networks and non-acute health care providers. These new agreements demonstrate the value of Vizient’s solutions and services for health care providers. “Providers nationwide are looking for ways to mitigate financial pressures. Vizient offersmore...
  • 12/04/19
    IRVING, Texas--(BUSINESS WIRE)--A continually evolving health care industry requires health care professionals who evolve right along with it. Vizient, Inc., the nation’s largest health care performance improvement company, today announced its participation at the Institute for Healthcare Improvement National Forum on Quality Improvement in Health Care. The annual event will be held Dec. 8-11 at the Marriott World Center in Orlando, Fla. Vizient is a sponsor of the event, and in addition tomore...
  • 12/03/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announces it will participate in an educational session on medication costs and drug shortages as well as host a series of informal question-and-answer sessions with pharmacy experts at the American Society of Health-Systems Pharmacists 2019 Midyear Clinical Meeting and Exhibition. With its focus on improving medication safety and patient care, the ASHP event, scheduled Dec. 8-12 in Las Vegas, is expected to be attended by more than 25,000 pharmacymore...
  • 11/21/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient today announced it has signed an agreement with Fresenius Kabi to supply six critical care drugs under Vizient’s successful Novaplus private label pharmacy program. The list includes propofol as well as five other acute, life-saving drugs: protamine, phenylephrine, oxytocin, thiamine and magnesium sulfate. Although Fresenius Kabi has been a trusted supplier to Vizient members for many years, this agreement makes these products the first critical caremore...
  • 11/19/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announced today it has been named a first-place winner in the 2019 Art of the Show Competition sponsored by the International Association of Exhibitions and Events. “The Art of Care Immersion Hallway,” featured at the Vizient Connections Business Summit in April, received Most Innovative Use of Technology for events under 75,000 net square feet. Vizient is the nation’s largest health care performance improvement company and annually produces themore...